Nanfang Hospital

Guangzhou, Guangdong 510515

1 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Kidney Neoplasms, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Metastatic Gastrointestinal Carcinoid Tumor, Neoplasm Metastasis, Neoplasms, Waldenstrom Macroglobulinemia

Studies at this site

• EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers — Recruiting now
• A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma — Running, not enrolling
• A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors — Completed
• APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia — Completed
• Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) — Completed
• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma — Completed
• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed